eltrombopag


( Last Updated : August 15, 2019)
Generic Name:
eltrombopag
Project Status:
Not filed
Manufacturer:
Novartis Pharmaceuticals Canada Inc.
Brand Name:
Revolade
Project Line:
Reimbursement Review
Project Number:
N/A

Details


Submission Type:
Non Submission
Indications:
Severe aplastic anemia
Recommendation Type:
CADTH is unable to recommend reimbursement as a submission was not filed by the manufacturer